You searched for "technological"
Hearing care systems in Europe – can we do more?
52 million Europeans experience hearing loss but many don’t find their way to professional hearing care. Lidia Best looks at strategies to improve the uptake of amplification at a national level [1]. With rising numbers of people experiencing hearing loss,...Genetics and the newborn hearing screen: the future is now
Eliot Shearer shares the progress being made with newborn hearing screening 60 years on from where it started, and future directions for identifying hearing loss using physiologic, genetic and cCMV screening. Newborn screening had its birth in the early 1960s,...NHS collaboration and partnership with the pharmaceutical and medical devices industries
Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...RSM ‘Otology Dragon’s Den’
The Royal Society of Medicine Otology Section recently held an ‘Otology Dragon’s Den’ event. Following on from our interview with Professor Gerry O’Donoghue, RSM Otology Section President, in the run-up to this event, we interviewed Steve Broomfield, Consultant Otologist in...The missing link: how migraine neurophysiology amplifies tinnitus
This article discusses an emerging hypothesis linking bothersome tinnitus with migraine-related sensory processing dysfunction. When evaluating patients with tinnitus, a range of contrasting experiences are noted, from mild, non-bothersome symptoms to those associated with significant distress – broadly corresponding to...Discovery in the genetics of complex disease: Otitis media
Otitis media (OM), a common disease of childhood, is considered to be a complex trait with multiple genetic and environmental factors expected to contribute to a child’s risk of developing recurrent acute OM (rAOM; ≥3 episodes in 6 months or...The changing spectrum of cancer of the oropharynx: dilemmas and future directions
The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....
What to do with incidental findings on FDG PET/CT?
18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG PET/CT) is commonly used in head and neck cancer staging. This investigation frequently identifies incidental findings unrelated to the index head and neck cancer. To assess the nature of these incidental findings, notes of...
Narrow band imaging in the management of carcinoma of unknown primary
This was a retrospective study to assess the utility of narrow band imaging (NBI) in the detection of a primary site in carcinoma of unknown primary (CUP). Patients with CUP who underwent transoral robotic surgery (TORS) and preoperative imaging with...
